Income-oriented investors tend to be attracted to Altria Group (NYSE: MO) due to its high yield of 8.6% and long history of increasing its dividend every year since 2009. However, revenue growth has ...
MO has been handsomely rewarded for the US FDA marketing approval of NJOY's menthol-flavored e-cigarette products, with the acquisition highly accretive to its existing tobacco portfolio. The ...
June 21 (UPI) --The U.S. Food and Drug Administration on Friday cleared four NJOY menthol-flavored e-cigarette products to be marketed in the United States. The FDA in a statement said it issued ...
Altria Group (NYSE:MO) and its operating company NJOY responded on Tuesday to the U.S. International Trade Commission Administrative Law Judge's initial determination regarding the patent infringement ...
The Food and Drug Administration’s first-ever authorization of menthol-flavored electronic cigarette devices may be a game-changer for public health for smokers trying to quit traditional cigarettes, ...
The FDA recently authorized the sale of four menthol-flavored NJOY products from Altria. NJOY could help the company return to revenue growth. The stock is inexpensive with a robust dividend that is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback